MicroRNA Expression and Function in Psoriasis II
Research type
Research Study
Full title
MicroRNA Expression and Function in Psoriasis II
IRAS ID
163330
Contact name
Kehinde Ross
Contact email
Research summary
MicroRNA Expression in Psoriasis
Increasing scientific evidence suggests that complex diseases like psoriasis are driven by small gene products called microRNAs. These molecules acts as "dimmer switches" that turn down gene expression. Alterations in microRNA levels in psoriatic skin compared to normal skin may contribute to the disease. In this study, the amounts of microRNAs in lesional and non-lesional psoriatic skin will be examined. Patients (no systemic treatments for at least 2 weeks and no active topical treatments apart from emollients for 1 week) will be recruited will be recruited from the Royal Liverpool and Broadgreen University Hospitals NHS Trust Dermatology clinic. Biopsies (6 mm) will be obtained under local anaesthesia from Biological molecules (RNA and microRNA) will be extracted using routine methods, and levels of these molecules will be assessed using established techniques. Together, with additional laboratory investigations, these studies will support the development of microRNA-based therapy for psoriasis.REC name
London - Fulham Research Ethics Committee
REC reference
14/LO/1711
Date of REC Opinion
19 Sep 2014
REC opinion
Further Information Favourable Opinion